Personal information

No personal information available

Activities

Collapse all

Employment (2)

南昌大学第一附属医院: 南昌, 江西省, CN

科主任 (血液科)
Employment
Source: Self-asserted source
Fei Li

First Affiliated Hospital of Nanchang University: Nanchang, Jiangxi, CN

2014-06-19 to present | associate director (Department of Hematology)
Employment
Source: Self-asserted source
Fei Li

Education and qualifications (4)

南昌大学第一附属医院: 南昌, 江西省, CN

2013-01-01 to 2015-12-12 | 博士 (血液科)
Education
Source: Self-asserted source
Fei Li

University of Iowa: Iowa City, IA, US

2014-08-01 to 2015-08-01 | postdoctoral (Department of Internal Medicine)
Education
Source: Self-asserted source
Fei Li

First Affiliated Hospital of Nanchang University: Nanchang, Jiangxi, CN

1997-06-30 to 2014-12 | M.D. and PH.D. (Department of Hematology)
Education
Source: Self-asserted source
Fei Li

Chinese Academy of Medical Sciences and Peking Union Medical College: Beijing, Beijing, CN

2010-09-01 to 2013-07-01 | M.D and PH.D. (hematology)
Education
Source: Self-asserted source
Fei Li

Works (13)

Hematopoietic stem cell microtransplantation: current situation and challenges

Therapeutic Advances in Hematology
2025-01 | Journal article
DOI: 10.1177/20406207241310332
Contributors: Zhengyang Li; Yuanyuan Yang; Hongwei Peng; Fei Li
Source: check_circle
Crossref

A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma

Clinical Cancer Research
2024-10-15 | Journal article
DOI: 10.1158/1078-0432.CCR-24-1194
Contributors: Jie Jin; Hong Cen; Keshu Zhou; Xiaohong Xu; Fei Li; Tao Wu; Haiyan Yang; Zhen Wang; Zhiming Li; Wenyang Huang et al.
Source: check_circle
Crossref

Data from A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma

2024-10-15 | Preprint
DOI: 10.1158/1078-0432.c.7494019
Contributors: Jie Jin; Hong Cen; Keshu Zhou; Xiaohong Xu; Fei Li; Tao Wu; Haiyan Yang; Zhen Wang; Zhiming Li; Wenyang Huang et al.
Source: check_circle
Crossref

Supplementary Data 1 from A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma

2024-10-15 | Preprint
DOI: 10.1158/1078-0432.27231343
Contributors: Jie Jin; Hong Cen; Keshu Zhou; Xiaohong Xu; Fei Li; Tao Wu; Haiyan Yang; Zhen Wang; Zhiming Li; Wenyang Huang et al.
Source: check_circle
Crossref

Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia

International Journal of General Medicine
2024-09 | Journal article
DOI: 10.2147/IJGM.S465184
Contributors: Ran Zhao; Dexiang Ji; Yulan Zhou; Ling Qi; Fei Li
Source: check_circle
Crossref

Refractory hemophagocytic lymphohistiocytosis secondary to polatuzumab vedotin plus rituximab and bendamustine

Annals of Hematology
2024-03 | Journal article
DOI: 10.1007/s00277-023-05598-4
Contributors: Kebing Lv; Fancong Kong; Min Yu; Yulan Zhou; Fei Li
Source: check_circle
Crossref

Increased levels of serum interleukin-10 are associated with poor outcome in adult hemophagocytic lymphohistiocytosis patients

Orphanet Journal of Rare Diseases
2021-12 | Journal article
DOI: 10.1186/s13023-021-01973-4
Contributors: Yulan Zhou; Fancong Kong; Shixuan Wang; Min Yu; Yawen Xu; Jing Kang; Songtao Tu; Fei Li
Source: check_circle
Crossref

Heterogeneous BCR-ABL1 signal patterns identified by fluorescence in situ hybridization are associated with leukemic clonal evolution and poorer prognosis in BCR-ABL1 positive leukemia

BMC Cancer
2019-12 | Journal article
DOI: 10.1186/s12885-019-6137-8
Contributors: Zhanglin Zhang; Zhiwei Chen; Mei Jiang; Shuyuan Liu; Yang Guo; Lagen Wan; Fei Li
Source: check_circle
Crossref

Haemophagocytic lymphohistiocytosis occurred during induction chemotherapy in an acute monocytic leukemia patient with FLT3-ITD and DNMT3A mutations

BMC Cancer
2018-12 | Journal article
DOI: 10.1186/s12885-018-4534-z
Contributors: Fei Li; Xiaojie Zhang; Yunyun Wang; Ailin Yang; Zhanglin Zhang; Weiping Tang; Nan Zhong; Huidong Shi
Source: check_circle
Crossref

Reactive Oxygen Species Contribute to TRAIL receptors upregulation; the mechanism for PH II-7 augmenting TRAIL induced apoptosis in leukemia cells

Eur J Pharmacol
2014-11 | Journal article
Source: Self-asserted source
Fei Li

Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma

Int J Cancer
2014-08 | Journal article
Source: Self-asserted source
Fei Li

Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China

Medical oncology
2014-03-01 | Journal article
Source: Self-asserted source
Fei Li

Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival

Leuk Res
2014-01 | Journal article
Source: Self-asserted source
Fei Li

Peer review (1 review for 1 publication/grant)

Review activity for Annals of hematology. (1)
How many people are using ORCID?